Most recently, she was with Bristol Myers Squibb, where she was Lead – Public Affairs for Middle East, Africa and India
The Organisation of Pharmaceutical Producers of India (OPPI), which represents the research-based pharmaceutical companies, has appointed Kanchana TK as its new Director General, with effect June 01, 2016. Kanchana takes over from Ranjana Smetacek, who has decided to relocate to the US. Kanchana brings almost two decades of professional experience across a range of healthcare-related businesses. Most recently, she was with Bristol Myers Squibb, where she was Lead – Public Affairs for Middle East, Africa and India.
Dr Shailesh Ayyangar, President, OPPI said, “I would like to thank Ranjana for her professionalism and leadership over the last three years at the OPPI and I am delighted to welcome Kanchana as her successor. With her sound experience in two highly-regulated sectors, insurance and pharmaceuticals, Kanchana brings a new strategic perspective to India’s evolving healthcare policy ecosystem.”
Speaking on her appointment, Kanchana TK said, “As Director General of OPPI, I look forward to the opportunity to contribute towards the growth of our industry and strengthen OPPI’s key role in finding ways to ensure quality healthcare is accessible to all. In my role, I will continue to drive advocacy programmes and work towards bringing diverse stakeholders together on issues related to Intellectual Property, Access to healthcare and Ethics in pharmaceutical marketing.”
- Advertisement -
Comments are closed.